Convert your Survodutide dose
Vial
Result
Converted amount0.6 mg
Dose mass600 mcg
Concentration2,500 mcg/mL
Draw volume0.24 mL
U-100 syringe24 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| Obesity / weight management (Phase 3 trial) | subcutaneous | 0.6–4.8 mg | Once weekly |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 600 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 0.3 mL | 30 units | 3 |
| 2 mg | 2 mL | 0.6 mL | 60 units | 3 |
| 2 mg | 3 mL | 0.9 mL | 90 units | 3 |
| 5 mg | 1 mL | 0.12 mL | 12 units | 8 |
| 5 mg | 2 mL | 0.24 mL | 24 units | 8 |
| 5 mg | 3 mL | 0.36 mL | 36 units | 8 |
| 10 mg | 1 mL | 0.06 mL | 6 units | 17 |
| 10 mg | 2 mL | 0.12 mL | 12 units | 17 |
| 10 mg | 3 mL | 0.18 mL | 18 units | 17 |
Calculated for the low end of the reported Obesity / weight management (Phase 3 trial) range. Change the dose in the calculator above for any other amount.
Survodutide at a glance
~1 week (supports once-weekly dosing; Tmax ~51h in dogs, extended mean residence time)
Half-life
Not established
Molecular weight — molar conversion unavailable
subcutaneous
Routes
research only
Legal status